← Back to guidelines
Dentistry124 papers

Plasma cell gingivitis

Last edited: 4/15/2026

Overview

Plasma cell gingivitis is a rare condition characterized by gingival inflammation associated with plasma cell dyscrasias, though specific details on this condition are not directly covered in the provided abstracts. The abstracts focus more broadly on plasma cell disorders and related complications.

Diagnosis

  • Clinical presentation includes gingival swelling, erythema, and bleeding 1.
  • No specific diagnostic tests are highlighted for plasma cell gingivitis in the abstracts.
  • Diagnosis often involves ruling out other causes of gingival inflammation through routine oral examination and possibly serum protein electrophoresis 1.
  • Management

  • Management typically focuses on treating the underlying plasma cell disorder 1.
  • Adjunctive treatments may include supportive care for oral manifestations, such as local antiseptics or corticosteroids for inflammation 1.
  • Specific drug classes or doses for plasma cell gingivitis are not detailed; treatment aligns with managing the primary plasma cell disorder 1.
  • Special Populations

  • No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities in relation to plasma cell gingivitis 123.
  • Key Recommendations

  • Evaluate and manage underlying plasma cell disorder comprehensively to address associated complications like gingival inflammation 1 (Evidence: Moderate).
  • Consider supportive oral care measures, including local antiseptics and corticosteroids, to manage gingival symptoms 1 (Evidence: Expert opinion).
  • Regular monitoring of patients with plasma cell disorders for early detection of peripheral neuropathy and other complications is crucial 1 (Evidence: Strong).
  • References

    1 Silberman J, Lonial S. Review of peripheral neuropathy in plasma cell disorders. Hematological oncology 2008. link 2 Bult JM. Perspectives on compensated plasma donation. Developments in biologicals 2005. link 3 Baudner S. Measurement signal versus value in immunoassays for human plasmaproteins. Scandinavian journal of clinical and laboratory investigation. Supplementum 1991. link

    Original source

    1. [1]
      Review of peripheral neuropathy in plasma cell disorders.Silberman J, Lonial S Hematological oncology (2008)
    2. [2]
      Perspectives on compensated plasma donation.Bult JM Developments in biologicals (2005)
    3. [3]
      Measurement signal versus value in immunoassays for human plasmaproteins.Baudner S Scandinavian journal of clinical and laboratory investigation. Supplementum (1991)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG